West Oak Capital, LLC Abb Vie Inc. Transaction History

West Oak Capital, LLC

$235 Million
Q1 2024

A detailed history of West Oak Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, West Oak Capital, LLC holds 9,546 shares of ABBV stock, worth $1.58 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

9,546

Previous 9,396 1.6%

Holding current value

$1.58 Million

Previous $1.53 Million 13.89%

% of portfolio

0.74%

Previous 0.71%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	BUY	$159.82 - $182.1 $23,973 - $27,315	150 Added 1.6%	9,546 $1.74 Million
Q4 2023 Jan 17, 2024	SELL	$137.6 - $154.97 $20,640 - $23,245	-150 Reduced 1.57%	9,396 $1.53 Million
Q3 2023 Oct 05, 2023	SELL	$133.59 - $154.65 $5,610 - $6,495	-42 Reduced 0.44%	9,546 $1.42 Million
Q2 2023 Jul 19, 2023	SELL	$132.51 - $164.9 $106,008 - $131,920	-800 Reduced 7.7%	9,588 $1.29 Million
Q1 2023 Apr 21, 2023	BUY	$144.61 - $166.54 $202,454 - $233,156	1,400 Added 15.58%	10,388 $1.66 Million

Q4 2022 Jan 05, 2023	SELL	$138.31 - $165.87 $133,469 - $160,064	-965 Reduced 9.7%	8,988 $1.45 Million
Q3 2022 Oct 28, 2022	BUY	$134.21 - $153.93 $25,499 - $29,246	190 Added 1.95%	9,953 $1.34 Million
Q2 2022 Jul 11, 2022	SELL	$137.62 - $174.96 $75,691 - $96,228	-550 Reduced 5.33%	9,763 $1.5 Million
Q1 2022 Apr 20, 2022	SELL	$131.98 - $163.75 $2,639 - $3,275	-20 Reduced 0.19%	10,313 $1.67 Million
Q4 2021 Jan 12, 2022	BUY	$107.43 - $135.93 $32,229 - $40,779	300 Added 2.99%	10,333 $1.4 Million
Q3 2021 Oct 07, 2021	BUY	$106.4 - $120.78 $4,788 - $5,435	45 Added 0.45%	10,033 $1.08 Million
Q2 2021 Jul 20, 2021	SELL	$105.21 - $117.21 $2,104 - $2,344	-20 Reduced 0.2%	9,988 $1.13 Million
Q1 2021 Apr 13, 2021	BUY	$102.3 - $112.62 $14,322 - $15,766	140 Added 1.42%	10,008 $1.08 Million
Q4 2020 Jan 08, 2021	BUY	$80.49 - $108.67 $28,171 - $38,034	350 Added 3.68%	9,868 $1.06 Million
Q3 2020 Oct 09, 2020	SELL	$85.91 - $100.83 $32,731 - $38,416	-381 Reduced 3.85%	9,518 $834,000
Q2 2020 Jul 06, 2020	BUY	$73.37 - $98.18 $11,372 - $15,217	155 Added 1.59%	9,899 $972,000
Q1 2020 Apr 07, 2020	BUY	$64.5 - $97.79 $39,345 - $59,651	610 Added 6.68%	9,744 $742,000
Q4 2019 Jan 09, 2020	SELL	$72.13 - $90.25 $21,639 - $27,075	-300 Reduced 3.18%	9,134 $809,000
Q2 2019 Jul 12, 2019	BUY	$65.7 - $83.98 $22,338 - $28,553	340 Added 3.74%	9,434 $686,000
Q1 2019 Apr 03, 2019	SELL	$77.14 - $90.79 $76,368 - $89,882	-990 Reduced 9.82%	9,094 $733,000
Q4 2018 Jan 08, 2019	SELL	$77.85 - $96.01 $28,570 - $35,235	-367 Reduced 3.51%	10,084 $930 Million
Q3 2018 Oct 04, 2018	BUY	$88.91 - $98.84 $929,198 - $1.03 Million	10,451 New	10,451 $988 Million
Q4 2017 Jan 05, 2018	SELL	$89.56 - $98.21 $1.28 Million - $1.41 Million	-14,314 Closed	0 $0
Q3 2017 Oct 10, 2017	BUY	$69.85 - $89.22 $999,832 - $1.28 Million	14,314	14,314 $1.27 Billion

Others Institutions Holding ABBV

# of Institutions

3,652

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $293B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of West Oak Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Oak Capital, LLC with notifications on news.

Account

West Oak Capital, LLC Abb Vie Inc. Transaction History